ATTEMPTS: A heparin/protamine-based delivery system for enzyme drugs

Journal of Controlled Release

Volumn 78, Issue 1-3, 2002, Pages 67-79

  Liang, J F ^a   Li, Y T ^a   Song, H ^a   Park, Y J ^a   Naik, S S ^a   Yang, V C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

ATTEMPTS; Enzyme therapy; Heparin; Prodrug; Protamine; Thrombolytic therapy; Tissue type plasminogen activator

Indexed keywords

ALTEPLASE; ANTIBODY; ARGININE; CYSTEINE; DNA; FIBRIN; FIBRIN ANTIBODY; HEPARIN; HEPARIN ANTAGONIST; PRODRUG; PROPIONIC ACID DERIVATIVE; PROTAMINE;

CHEMICAL INTERACTION; CHEMICAL MODIFICATION; COMPLEX FORMATION; COMPUTER SIMULATION; CONFERENCE PAPER; DNA RECOMBINATION; DRUG BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENZYME RELEASE; FIBRINOLYTIC THERAPY; PRIORITY JOURNAL;

BASE SEQUENCE; COMPUTER SIMULATION; DNA, RECOMBINANT; DRUG DELIVERY SYSTEMS; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MOLECULAR SEQUENCE DATA; PROTAMINES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0037122735     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00484-9     Document Type: Conference Paper

References (25)

1. Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster models
2. The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia
3. Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent
4. Tumor-targeting chemotherapy by a xanthine oxidase-polymer conjugate that generates oxygen-free radicals in tumor sites
5. Strategies for the improvement of thrombolytic agents
6. Anticoagulant, thrombolytics, and antiplatelet drugs
7. Antibody-directed enzyme prodrug therapy (ADEPT): A review
8. Antibody-directed enzyme prodrug therapy (ADEPT): A review of some theoretical, experimental and clinical aspects
9. Prodrug of thymidylate synthase inhibitors: Potential for antibody directed enzyme prodrug therapy (ADEPT)
10. Antibody-directed prodrug therapy (ADEPT). A three phase study in ovarian tumour xenografts
11. Delivery system for targeted thrombolysis without the risk of hemorrhage
12. A recombinant pro-drug type approach for triggered delivery of streptokinase
13. Synthesis and characterization of positive charged tPA as a prodrug using heparin/protamine drug delivery system
14. 7 chimera for targeted thrombolysis without the bleeding risk
15. An investigation of heparinase immobilization
16. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs
17. Low molecular weight protamine: A potential non-toxic heparin antagonist
18. Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli
19. A recombinant t-PA for targeted thrombolysis without the risk of bleeding
20. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator with plasminogen activator inhibitor 1
21. Crystalline structure of heparin
22. A crystal structure of the catalytic domain of recombinant two-chain human tissue plasminogen activator
23. Molecular modeling of protein-glycosminoglycan interactions